1Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005 [ J]. CA Cancer J Clin, 2005, 55:10-30.
2Leonard G D, Swain S M. Ductal carcinoma in situ, complexities and challenges[ J]. J Natl Cancer Inst,2004, 96: 906- 920.
3Erbas B, Provenzano E, Armes J, et al. The natural history of ductal carcinoma in situ of the breast: a review[ J ]. Breast Cancer Res Treat,2006, 97 : 135 - 144.
4Sanders M E, Schuyler P A, Dupont W D, et al. The nature history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up [J]. Cancer,2005, 103:2481 -2484.
5Dupont W D, Page D L. Risk factors of breast cancer in women with proliferative breast disease [ J ]. N Engl J Med, 1985, 312: 146 - 151.
6O'Connell P, Pekkel V, Fuqua S A, et al. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci [J]. J Nat Cancer Inst,1998, 90:697 -703.
7Singletary S E. A working model for the time sequence of genetic changes in breast tumorigenesis[ J]. J Am Coll Surg, 2002, 194: 202 -216.
8Simpson P T, Reis-Filho J S, Gale T, et al. Molecular evolution of breast cancer[ J]. J Pathol,2005, 205 : 248 - 254.
9Sontag L, Axelrod D E. Evaluation of pathways for progression of heterogeneous breast tumors [ J ]. J Theor Biol, 2005,232 : 179 - 189.
10Giardina C, Serio G, Lepore G, et al. Pure ductal carcinoma in situ and in situ component of invasive carcinoma of the breast. A preliminary morphometric study [ J ]. J Exp Clin Cancer Res, 2003,22 : 279 - 288.
2Londero V, Zuiani C, Furlan A, et al. Role of ultrasound and sonographically guided biopsy in the diagnostic evaluation of dutal carcinoma in situ of the breast [J]. Radiol Med, 2007, 11(2): 863-876.
3Nagashima T, Hashimoto H, Oshita K, et al. Ultrasound demonstration of mammographically detected mierocalcification in patients with dural carcinoma in situ of the breast[J]. Berast cancer, 2005, 12(3): 216-220.
4Moon WK, Myung FS, Lee YF, et al. US of ductal carcinoma in situ[J]. Radiographics, 2002, 22(2): 269-281.
5付丽.乳腺肿瘤病理学[M].北京:人民卫生出版社,2007:121.
6Bijker N, Rutgers E J, Peterse JL, et al. Variations in diagnostic and ther- apeutic procedures in a multicentre, randomized clinical trial (EORTC 10853 ) investigating breast conserving treatment for DCIS [J]. Eur JSurg Onco1,2001,27 (2) : 135-140.
7Muthuswamy S K,Li D,Lelievre S,et al.ErbB2,but not ErbB1,reinitiates proliferation and induces luminal repopulation in epithelial acini[J].Nat Cell Biol,2001,9(3):785-92.
8Andrechek E R,Laing M A,Girgis-Gabardo A A,et al.Gene expression profiling of neu-induced mammary tumors from transgenic mice reveals genetic and morphological similarities to ErbB2-expressing human breast cancers[J].Cancer Res,2003,63(16):4920-6.
9Tarin D.The fallacy of epithelial mesenchymal transition in neoplasia[J].Cancer Res,2005,65(14):5996-6000.
10Ledford H.Cancer theory faces doubts[J].Nature,2011,472:273.
